isoproterenol has been researched along with thalidomide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Botting, JH | 1 |
Arya, DS; Kishore, K; Kumari, S; Loh, HK; Nag, TC; Ray, R; Sahoo, KC | 1 |
Cachofeiro, V; Davel, AP; De Sá, LL; Fukuda, LE; Lahera, V; Munhoz, CD; Rossoni, LV; Sanz-Rosa, D; Scavone, C | 1 |
1 review(s) available for isoproterenol and thalidomide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for isoproterenol and thalidomide
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Animal research. Various fallacies persist in vivisection debate.
Topics: Abnormalities, Drug-Induced; Animal Welfare; Animals; Bronchodilator Agents; Drug Evaluation, Preclinical; Humans; Isoproterenol; Teratogens; Thalidomide | 2001 |
Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
Topics: Administration, Oral; Animals; Blood Pressure; Dose-Response Relationship, Drug; Endocardium; Heart; Heart Injuries; Heart Rate; Immunosuppressive Agents; Injections, Subcutaneous; Isoproterenol; Male; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardium; Myofibrils; Rats; Rats, Wistar; Thalidomide; Ventricular Function, Left; Ventricular Pressure | 2007 |
Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta.
Topics: Acetylcholine; Adrenergic beta-Agonists; Animals; Aorta; Blotting, Western; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Injections, Subcutaneous; Interleukin-1beta; Interleukin-6; Isoproterenol; Male; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium Salicylate; Superoxide Dismutase; Thalidomide; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2008 |